logo

Conatus Pharmaceuticals Inc (CNAT)



Trade CNAT now with
  Date
  Headline
8/31/2017 4:09:08 PM Conatus Pharmaceuticals Appoints Keith Marshall As EVP, COO And CFO
6/26/2017 7:03:05 AM FDA Grants Conatus Orphan Drug Designation For IDN-7314 For Treatment Of PSC
5/11/2017 9:03:38 AM Conatus Pharma Announces Pricing Of Public Offering Of Common Stock
5/4/2017 1:27:39 AM Conatus Announces Exercise Of License Option For Global Development And Commercialization Of Emricasan
3/15/2017 4:26:12 PM Conatus Pharma Q4 Loss/share $0.35 Vs. Loss $0.30 Year Ago
2/7/2017 7:35:26 AM Conatus Appoints William LaRue As An Additional Independent Member